首頁 > 市場調查報告書 > 醫療設備

感染疾病

市場調查報告書

商品編碼

1525913

全球人類和動物健康感染控制市場:按產品類型(消毒產品,個人防護設備,滅菌設備),感染類型和最終用戶進行預測 (-2032)

Global Infection Control for the Human and Animal Health Market Research Report Information by Product (Disinfection Products, Personal Protective Equipment, and Sterilization Equipment ), by Infection Type, by End Us - Forecast to 2032

出版日期: 2024年07月15日 | 出版商:

Market Research Future | 英文 187 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

根據預測，人類和動物健康感染控制市場規模將從2023年的95.6億美元成長到2032年的209.5億美元，預測期內複合年增長率為8.16%。

傳染病爆發是人類和動物健康感染控制市場的主要驅動力。近年來，全球許多傳染病的發生率顯著增加，增加了對感染控制產品和方法的需求。

對感染控制技術的認識不斷提高是人類和動物健康市場的主要驅動力。最近的流行病和全球健康危機提高了公眾和專業人士對感染預防必要性的認識。增加媒體報導、教育活動和政府措施都有助於提高公民和醫療保健界的知識。個人和醫療保健專業人員都瞭解對消毒產品、個人防護裝備 (PPE) 和無菌設備的需求，以防止傳染病的傳播。許多環境（包括醫院、診所和公共設施）對感染控制的日益重視，增加了對創新和有效的感染控制系統的需求。

區域洞察

2022年北美地區佔有率最大，超過33.75%。這是由於該地區先進的醫療基礎設施、嚴格的法規、高度的感染控制意識以及手術數量的增加。個人防護裝備經常用於骨科手術，以防止病患和醫護人員感染。

由於歐洲各地感染病例數量不斷增加，預計歐洲人類和動物健康感染控制市場將在預測期內顯著擴大。

亞太地區是一個充滿活力且多元化的市場。人口的快速增長、城市化進程的加速以及醫療保健相關標準意識的提高，都增加了對有效感染預防和控制策略的需求。

該報告調查了全球人類和動物健康感染控制市場，並提供了市場定義和概述、市場成長影響因素和市場機會分析、市場規模趨勢和預測、各種細分，並總結了按地區/主要國家、競爭環境劃分的細分情況，以及主要公司的簡介。

Global Infection Control for the Human and Animal Health Market Research Report Information by Product (Disinfection Products [Liquid Disinfectants, Disinfectant Wipes, Disinfectant Sprays, and Others], Personal Protective Equipment (PPE) [Gloves, Masks, Gowns, Protective Eyewear, and Others], and Sterilization Equipment [Heat Sterilization Equipment, Low-temperature Sterilization Equipment, Radiation Sterilization Equipment, and Filtration Sterilization Equipment]), by Infection Type (Viral, Bacterial, Parasitic, and Fungal Infections), by End Us (Human Healthcare Facilities and Animal Healthcare facilities)- Forecast to 2032

Market Overview

The Infection Control for Human and Animal Health Market industry is expected to increase from USD 9.56 billion in 2023 to USD 20.95 billion by 2032, with a compound yearly growth rate (CAGR) of 8.16% over the forecast period (2023-2032).

The rising prevalence of infectious diseases is a major driver of infection control in the human and animal health markets. In recent years, there has been a significant increase in the frequency of numerous infectious diseases around the world, resulting in increased demand for infection control products and methods.

Rising awareness of infection control techniques is a key driver for the human and animal health markets. The recent pandemics and global health crises have heightened public and professional awareness of the necessity of infection prevention. Increased media coverage, educational campaigns, and government measures have all contributed to a better knowledgeable public and healthcare community. Individuals and healthcare professionals alike understand the need of disinfection products, personal protective equipment (PPE), and sterilizing equipment in preventing the spread of infectious diseases. The rising emphasis on infection control practices in many contexts, including hospitals, clinics, and public areas, has resulted in an increase in demand for innovative and effective infection control systems.

Market Segment insights

The Infection Control for Human and Animal Health Market is divided into three product categories: disinfection, personal protective equipment (PPE), and sterilization.

The market has been divided into four types of infections: viral, bacterial, parasitic, and fungal.

The market is divided into two segments based on end users: human healthcare facilities and animal healthcare facilities.

Regional insights

North America had the biggest market share of more than 33.75% in 2022, owing to the region's sophisticated healthcare infrastructure, tight regulations, high awareness of infection control measures, and increasing number of surgical procedures. PPE is often used in orthopedic surgery to avoid infections in both patients and healthcare staff. According to the American Joint Replacement Registry's annual report for 2021, 2,244,587 hip and knee operations were conducted.

Europe's infection control market for human and animal health is expected to rise significantly during the forecast year, 2022-2023, due to an increase in infection cases across Europe. The infection control industry in Europe, which includes both human and animal health, is seeing a significant spike, driven by increased awareness of infectious illnesses and the demand for better preventive measures. According to the World Health Organization, on June 26, 2023, Croatia, Italy, Spain, Sweden, and the United Kingdom of Great Britain and Northern Ireland reported an increase in confirmed cases of E-11 infection in neonates and babies, with substantial morbidity and death.

The Asia-Pacific area is a vibrant and diversified market for infection control in human and animal health. With a fast-growing population, more urbanization, and rising awareness of healthcare standards, there is a greater need for effective infection prevention and control strategies. According to the United Nations Population Fund (UNFPA), Asia and the Pacific make up 60% of the world's population, or around 4.3 billion people.

Major Players

Advanced Sterilization Products (US), STERIS plc (Ireland), Getinge AB (Sweden), Virox Technologies, Inc. (Canada), 3M (US), Zoetis Animal Healthcare (US), PeproTech Sciences Inc (Canada), Neogen Corporation (US), Cardinal Health (US), and Stryker (US) are among the key players in the Infection Control for Human and Animal Health Market.

1 MARKET INTRODUCTION

1.1 DEFINITION
1.2 SCOPE OF THE STUDY
1.3 RESEARCH OBJECTIVE
1.4 MARKET STRUCTURE

2 RESEARCH METHODOLOGY

2.1 OVERVIEW
2.2 DATA FLOW
- 2.2.1 DATA MINING PROCESS
2.3 PURCHASED DATABASE:
2.4 SECONDARY SOURCES:
- 2.4.1 SECONDARY RESEARCH DATA FLOW:
2.5 PRIMARY RESEARCH:
- 2.5.1 PRIMARY RESEARCH DATA FLOW:
- 2.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED
2.6 APPROACHES FOR MARKET SIZE ESTIMATION:
- 2.6.1 REVENUE ANALYSIS APPROACH
2.7 DATA FORECASTING
- 2.7.1 DATA FORECASTING TECHNIQUE
2.8 DATA FORMULATIONLING
- 2.8.1 MICROECONOMIC FACTOR ANALYSIS:
- 2.8.2 DATA FORMULATIONLING:
2.9 TEAMS AND ANALYST CONTRIBUTION

3 MARKET DYNAMICS

3.1 INTRODUCTION
3.2 DRIVERS
- 3.2.1 INCREASING PREVALENCE OF INFECTIOUS DISEASES
- 3.2.2 RISING AWARENESS OF INFECTION CONTROL MEASURES
3.3 RESTRAINTS
- 3.3.1 COST CONSTRAINTS IN INFECTION CONTROL
3.4 OPPORTUNITY
- 3.4.1 GROWING DEMAND FOR TECHNOLOGICALLY ADVANCED AND SUSTAINABLE INFECTION CONTROL SOLUTIONS

4 MARKET FACTOR ANALYSIS

4.1 VALUE CHAIN ANALYSIS
- 4.1.1 R&D
- 4.1.2 MANUFACTURING
- 4.1.3 DISTRIBUTION AND SALES
- 4.1.4 POST-SALES MONITORING
4.2 PORTER'S FIVE FORCES MODEL
- 4.2.1 THREAT OF NEW ENTRANTS
- 4.2.2 BARGAINING POWER OF SUPPLIERS
- 4.2.3 THREAT OF SUBSTITUTES
- 4.2.4 BARGAINING POWER OF BUYERS
- 4.2.5 INTENSITY OF RIVALRY
4.3 IMPACT OF COVID-19 ON THE GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET
- 4.3.1 IMPACT ON SUPPLY CHAIN
- 4.3.2 IMPACT ON MARKET PLAYERS

5 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT

5.1 OVERVIEW
5.2 DISINFECTION PRODUCTS
- 5.2.1 LIQUID DISINFECTANTS
- 5.2.2 DISINFECTANT WIPES
- 5.2.3 DISINFECTANT SPRAYS
- 5.2.4 OTHERS
5.3 PERSONAL PROTECTIVE EQUIPMENT (PPE)
- 5.3.1 GLOVES
- 5.3.2 MASKS
- 5.3.3 GOWNS
- 5.3.4 PROTECTIVE EYEWEAR
- 5.3.5 OTHERS
5.4 STERILIZATION EQUIPMENT
- 5.4.1 HEAT STERILIZATION EQUIPMENT
- 5.4.2 LOW-TEMPERATURE STERILIZATION EQUIPMENT
- 5.4.3 RADIATION STERILIZATION EQUIPMENT
- 5.4.4 FILTRATION STERILIZATION EQUIPMENT
- 5.4.5 OTHERS

6 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE

6.1 OVERVIEW
6.2 VIRAL
6.3 BACTERIAL
6.4 PARASITIC
6.5 FUNGAL INFECTIONS

7 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER

7.1 OVERVIEW
7.2 HUMAN HEALTHCARE FACILITIES
- 7.2.1 HOSPITALS & CLINICS
- 7.2.2 AMBULATORY SURGICAL CENTERS
- 7.2.3 OTHERS
7.3 ANIMAL HEALTHCARE FACILITIES
- 7.3.1 VETERINARY HOSPITALS
- 7.3.2 ANIMAL SHELTERS
- 7.3.3 FARMING FACILITIES
- 7.3.4 OTHERS

8 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY REGION

8.1 OVERVIEW
8.2 NORTH AMERICA
- 8.2.1 US
- 8.2.2 CANADA
8.3 EUROPE
- 8.3.1 GERMANY
- 8.3.2 FRANCE
- 8.3.3 UK
- 8.3.4 ITALY
- 8.3.5 SPAIN
- 8.3.6 REST OF EUROPE
8.4 ASIA-PACIFIC
- 8.4.1 CHINA
- 8.4.2 INDIA
- 8.4.3 JAPAN
- 8.4.4 AUSTRALIA
- 8.4.5 SOUTH KOREA
- 8.4.6 REST OF ASIA-PACIFIC
8.5 REST OF THE WORLD
- 8.5.1 REST OF THE WORLD
- 8.5.2 MIDDLE EAST & AFRICA
- 8.5.3 SOUTH AMERICA

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION
9.2 MARKET SHARE ANALYSIS,
9.3 COMPETITOR DASHBOARD
9.4 PUBLIC PLAYERS STOCK SUMMARY
9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
9.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
- 9.6.1 PRODUCT LAUNCH

10 COMPANY PROFILE

10.1 3M
- 10.1.1 COMPANY OVERVIEW
- 10.1.2 FINANCIAL OVERVIEW
- 10.1.3 PRODUCTS OFFERED
- 10.1.4 KEY DEVELOPMENTS
- 10.1.5 SWOT ANALYSIS
- 10.1.6 KEY STRATEGIES
10.2 ZOETIS ANIMAL HEALTHCARE
- 10.2.1 COMPANY OVERVIEW
- 10.2.2 FINANCIAL OVERVIEW
- 10.2.3 PRODUCTS OFFERED
- 10.2.4 KEY DEVELOPMENTS
- 10.2.5 SWOT ANALYSIS
- 10.2.6 KEY STRATEGIES
10.3 PEROTECH SCIENCES INC.
- 10.3.1 COMPANY OVERVIEW
- 10.3.2 FINANCIAL OVERVIEW
- 10.3.3 PRODUCTS OFFERED
- 10.3.4 KEY DEVELOPMENTS
- 10.3.5 KEY STRATEGIES
10.4 STERIS PLC
- 10.4.1 COMPANY OVERVIEW
- 10.4.2 FINANCIAL OVERVIEW
- 10.4.3 PRODUCTS OFFERED
- 10.4.4 KEY DEVELOPMENTS
- 10.4.5 SWOT ANALYSIS
- 10.4.6 KEY STRATEGY
10.5 GETINGE AB
- 10.5.1 COMPANY OVERVIEW
- 10.5.2 FINANCIAL OVERVIEW
- 10.5.3 PRODUCTS OFFERED
- 10.5.4 KEY DEVELOPMENTS
- 10.5.5 SWOT ANALYSIS
- 10.5.6 KEY STRATEGY
10.6 VIROX TECHNOLOGIES, INC.
- 10.6.1 COMPANY OVERVIEW
- 10.6.2 FINANCIAL OVERVIEW
- 10.6.3 PRODUCTS OFFERED
- 10.6.4 KEY DEVELOPMENTS
- 10.6.5 KEY STRATEGIES
10.7 ADVANCED STERILIZATION PRODUCTS
- 10.7.1 COMPANY OVERVIEW
- 10.7.2 FINANCIAL OVERVIEW
- 10.7.3 PRODUCTS OFFERED
- 10.7.4 KEY DEVELOPMENTS
- 10.7.5 KEY STRATEGIES
10.8 NEOGEN CORPORATION
- 10.8.1 COMPANY OVERVIEW
- 10.8.2 FINANCIAL OVERVIEW
- 10.8.3 PRODUCTS OFFERED
- 10.8.4 KEY DEVELOPMENTS
- 10.8.5 SWOT ANALYSIS
- 10.8.6 KEY STRATEGIES
10.9 CARDINAL HEALTH
- 10.9.1 COMPANY OVERVIEW
- 10.9.2 FINANCIAL OVERVIEW
- 10.9.3 PRODUCTS OFFERED
- 10.9.4 KEY DEVELOPMENTS
- 10.9.5 KEY STRATEGIES
10.10 STRYKER
- 10.10.1 COMPANY OVERVIEW
- 10.10.2 FINANCIAL OVERVIEW
- 10.10.3 PRODUCTS OFFERED
- 10.10.4 KEY DEVELOPMENTS
- 10.10.5 KEY STRATEGIES

11 DATA CITATIONS

簡介目錄圖表

LIST OF TABLES

TABLE 1 QFD MODELLING FOR MARKET SHARE ASSESSMENT
TABLE 2 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 3 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY REGION, 2019-2032 (USD MILLION)
TABLE 4 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 5 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY LIQUID DISINFECTANTS, BY REGION, 2019-2032 (USD MILLION)
TABLE 6 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTANT WIPES, BY REGION, 2019-2032 (USD MILLION)
TABLE 7 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTANT SPRAYS, BY REGION, 2019-2032 (USD MILLION)
TABLE 8 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 9 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PERSONAL PROTECTIVE EQUIPMENT (PPE), BY REGION, 2019-2032 (USD MILLION)
TABLE 10 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE, 2019-2032 (USD MILLION)
TABLE 11 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY GLOVES, BY REGION, 2019-2032 (USD MILLION)
TABLE 12 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY MASKS, BY REGION, 2019-2032 (USD MILLION)
TABLE 13 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY GOWNS, BY REGION, 2019-2032 (USD MILLION)
TABLE 14 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PROTECTIVE EYEWEAR, BY REGION, 2019-2032 (USD MILLION)
TABLE 15 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 16 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY REGION, 2019-2032 (USD MILLION)
TABLE 17 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 18 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HEAT STERILIZATION EQUIPMENT, BY REGION, 2019-2032 (USD MILLION)
TABLE 19 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY LOW-TEMPERATURE STERILIZATION EQUIPMENT, BY REGION, 2019-2032 (USD MILLION)
TABLE 20 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY RADIATION STERILIZATION EQUIPMENT, BY REGION, 2019-2032 (USD MILLION)
TABLE 21 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY FILTRATION STERILIZATION EQUIPMENT, BY REGION, 2019-2032 (USD MILLION)
TABLE 22 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 23 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 24 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY VIRAL, BY REGION, 2019-2032 (USD MILLION)
TABLE 25 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY BACTERIAL, BY REGION, 2019-2032 (USD MILLION)
TABLE 26 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PARASITIC, BY REGION, 2019-2032 (USD MILLION)
TABLE 27 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY FUNGAL INFECTIONS, BY REGION, 2019-2032 (USD MILLION)
TABLE 28 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 29 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY REGION, 2019-2032 (USD MILLION)
TABLE 30 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 31 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION)
TABLE 32 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 33 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 34 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY REGION, 2019-2032 (USD MILLION)
TABLE 35 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 36 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY VETERINARY HOSPITALS, BY REGION, 2019-2032 (USD MILLION)
TABLE 37 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL SHELTERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 38 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY FARMING FACILITIES, BY REGION, 2019-2032 (USD MILLION)
TABLE 39 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY OTHERS, BY REGION, 2019-2032 (USD MILLION)
TABLE 40 GLOBAL: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 41 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 42 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 43 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 44 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 45 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 46 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 47 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 48 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 49 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 50 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 51 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 52 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 53 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 54 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 55 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 56 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 57 US: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 58 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 59 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 60 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 61 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 62 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 63 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 64 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 65 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 66 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 67 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 68 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 69 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 70 CANADA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 71 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 72 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 73 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 74 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 75 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 76 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 77 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 78 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 79 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 80 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 81 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 82 GERMANY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 83 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 84 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 85 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 86 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 87 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 88 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 89 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 90 FRANCE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 91 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 92 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 93 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 94 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 95 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 96 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 97 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 98 UK: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 99 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 100 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 101 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 102 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 103 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 104 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 105 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 106 ITALY: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 107 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 108 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 109 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 110 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 111 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 112 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 113 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 114 SPAIN: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 115 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 116 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR DISINFECTION PRODUCTS BY TYPE 2019-2032 (USD MILLION)
TABLE 117 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR PERSONAL PROTECTIVE EQUIPMENT (PPE), BY TYPE 2019-2032 (USD MILLION)
TABLE 118 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET FOR STERILIZATION EQUIPMENT, BY TYPE 2019-2032 (USD MILLION)
TABLE 119 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 120 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 121 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY HUMAN HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 122 REST OF EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY ANIMAL HEALTHCARE FACILITIES, BY TYPE 2019-2032 (USD MILLION)
TABLE 123 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2019-2032 (USD MILLION)
TABLE 124 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 125 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 126 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 127 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 128 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 129 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 130 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 131 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 132 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 133 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 134 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 135 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 136 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 137 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 138 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 139 CHINA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 140 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 141 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 142 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 143 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 144 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 145 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 146 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 147 INDIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 148 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 149 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 150 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 151 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 152 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 153 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 154 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 155 JAPAN: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 156 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 157 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 158 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 159 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 160 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 161 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 162 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 163 AUSTRALIA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 164 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 165 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 166 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 167 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 168 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 169 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 170 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 171 SOUTH KOREA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 172 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 173 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 174 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 175 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 176 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 177 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 178 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 179 REST OF ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 180 REST OT THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY REGION, 2019-2032 (USD MILLION)
TABLE 181 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 182 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 183 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 184 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 185 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 186 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 187 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 188 REST OF THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 189 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 190 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 191 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 192 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 193 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 194 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 195 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 196 MIDDLE EAST & AFRICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 197 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2019-2032 (USD MILLION)
TABLE 198 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR DISINFECTION PRODUCTS, BY TYPE, 2019-2032 (USD MILLION)
TABLE 199 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR PERSONAL PROTECTIBVE EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 200 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR STERILIZATION EQUIPMENT, BY TYPE, 2019-2032 (USD MILLION)
TABLE 201 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2019-2032 (USD MILLION)
TABLE 202 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2019-2032 (USD MILLION)
TABLE 203 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR HUMAN HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 204 SOUTH AMERICA: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, FOR ANIMAL HEALTHCARE FACILITIES, BY TYPE, 2019-2032 (USD MILLION)
TABLE 205 PUBLIC PLAYERS STOCK SUMMARY
TABLE 206 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
TABLE 207 PRODUCT LAUNCH
TABLE 208 3M: PRODUCTS OFFERED
TABLE 209 ZOETIS ANIMAL HEALTHCARE: PRODUCTS OFFERED
TABLE 210 PEROTECH SCIENCES INC.: PRODCUTS OFFERED
TABLE 211 STERIS PLC: PRODCUTS OFFERED
TABLE 212 GETINGE AB: PRODUCTS OFFERED
TABLE 213 VIROX TECHNOLOGIES, INC.: PRODUCTS OFFERED
TABLE 214 ADVANCED STERILIZATION PRODUCTS: PRODUCTS OFFERED
TABLE 215 ADVANCED STERILIZATION PRODUCTS: KEY DEVELOPMENTS
TABLE 216 NEOGEN CORPORATION: PRODUCT OFFERED
TABLE 217 NEOGEN CORPORATION: KEY DEVELOPMENTS
TABLE 218 CARDINAL HEALTH: PRODUCT OFFERED
TABLE 219 CARDINAL HEALTH: KEY DEVELOPMENTS
TABLE 220 STRYKER: PRODUCT OFFERED
TABLE 221 STRYKER: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET: STRUCTURE
FIGURE 2 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET: MARKET GROWTH FACTOR ANALYSIS (2022-2032)
FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)
FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032)
FIGURE 5 VALUE CHAIN ANALYSIS OF THE GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET
FIGURE 6 PORTER'S FIVE FORCES ANALYSIS: GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET
FIGURE 7 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY PRODUCT, 2022 & 2032 (USD MILLION)
FIGURE 8 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY PRODUCT,
FIGURE 9 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY INFECTION TYPE, 2022 & 2032 (USD MILLION)
FIGURE 10 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY INFECTION TYPE,
FIGURE 11 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY END USER, 2022 & 2032 (USD MILLION)
FIGURE 12 GLOBAL INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY END USER,
FIGURE 13 GLOBAL: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY REGION, 2022 & 2032 (USD MILLION)
FIGURE 14 GLOBAL: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY REGION,
FIGURE 15 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
FIGURE 16 NORTH AMERICA: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY COUNTRY,
FIGURE 17 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
FIGURE 18 EUROPE: INFECTION CONTROL FOR THE HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY COUNTRY,
FIGURE 19 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY COUNTRY, 2022 & 2030 (USD MILLION)
FIGURE 20 ASIA-PACIFIC: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY COUNTRY,
FIGURE 21 REST OT THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET, BY REGION, 2022 & 2030 (USD MILLION)
FIGURE 22 REST OT THE WORLD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET SHARE (%), BY REGION,
FIGURE 23 INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET PLAYERS: COMPETITIVE ANALSIS,
FIGURE 24 COMPETITOR DASHBOARD: INFECTION CONTROL IN HUMAN AND ANIMAL HEALTH MARKET
FIGURE 25 3M: FINANCIAL OVERVIEW
FIGURE 26 3M: SWOT ANALYSIS
FIGURE 27 ZOETIS ANIMAL HEALTHCARE: PRODUCTS OFFERED
FIGURE 28 ZOETIS ANIMAL HEALTHCARE: SWOT ANALYSIS
FIGURE 29 STERIS PLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 STERIS PLC: SWOT ANALYSIS
FIGURE 31 GETINGE AB: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 GETINGE AB: SWOT ANALYSIS
FIGURE 33 NEOGEN CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 34 NEOGEN CORPORATION: SWOT ANALYSIS
FIGURE 35 CARDINAL HEALTH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 36 STRYKER: FINANCIAL OVERVIEW SNAPSHOT